AKVA group ASA: Notice of Annual General Meeting 2024
The shareholders in AKVA group ASA are invited to attend the Annual General Meeting to be held at 15:00 hours (CEST) on Thursday, 2 May 2024.
Please find enclosed the notice of the Annual General Meeting including attendance form and proxy forms, the Board's report on salaries and other remuneration to executive personnel, the recommendations of the Nomination Committee and the proposed new articles of association. The documents related to the Annual General Meeting, including the Annual Report for 2023, are available on the company's website https://www.akvagroup.com/investors/general-meeting/.
The Annual General Meeting will be held as a digital meeting only. Shareholders who wish to attend the general meeting via video link are asked to notify the company by email to [email protected] no later than Monday, 29 April 2024, at 15:00 (CEST). Such shareholders will then receive an invite to the meeting together with information on digital attendance and voting. Shareholders are encouraged to attend the General Meeting by granting a proxy to the chairman of the Board, with or without voting instructions. For further details on how to attend the General Meeting, see page 5 of the attached notice.
Dated: 8 April 2024
AKVA group ASA
Web: www.akvagroup.com
CONTACTS:
| Knut Nesse | Chief Executive Officer |
| Phone: | +47 51 77 85 00 |
| Mobile: | +47 91 37 62 20 |
| E-mail: | [email protected] |
| Ronny Meinkøhn | Chief Financial Officer |
| Phone: | +47 51 77 85 00 |
| Mobile: | +47 98 20 67 76 |
| E-mail: | [email protected] |
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachments
- Notice of AGM - AKVA group
- Innkalling til OGF - AKVA group
- Recommendations from the Nomination Committee 2024 - AKVA group
- Remuneration report 2023 - AKVA group
- Proposed new articles of association - AKVA group
- Redline proposed new articles of association - AKVA group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
- 40 Acres And A Profit Launches The Levi Bean Lake Real Estate Course Built on Real Houses and $1M+ in Capital
- Simple Expands Retail POS Nationwide With 22+ Modules at $99 Per Month
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share